Company: PHR
Filing Date: 2025-05-14
Form Type: DEF 14A
Source: 0001412408-25-000027
Chunk: 39

Company: Phreesia, Inc.
Filing Date: 2025-05-14
Form: DEF 14A
Chunk 39
---
 (iv) 91,045 shares of common stock held in the Michael Weintraub 2023 Qualified Annuity Trust (the "GRAT") and 6,703 shares of common stock held in the Weintraub Family 2017 Irrevocable Trust (the "2017 Trust"). The GRAT is a grantor retained annuity trust of which Mr. Weintraub is the trustee and of which the 2017 Trust is

<div align='center'>29</div>

the beneficiary. Members of Mr. Weintraub's immediate family are the sole beneficiaries of the 2017 Trust.

(4) Includes an additional $82,500 in cash fees awarded as a result of Mr. Weintraub’s contributions during the fiscal year ended January 31, 2025. Mr. Weintraub's annual cash fees are capped at $200,000.

(5) As of January 31, 2025, Ms. Munson held (i) 10,216 shares of common stock, (ii) options to purchase 42,096 shares of our common stock and (iii) 26,858 DSUs.

(6) As of January 31, 2025, Dr. Smith held (i) 6,110 shares of common stock, (ii) options to purchase 58,193 shares of our common stock and (iii) 24,543 DSUs.

(7) As of January 31, 2025, Ms. Goldstein held (i) 11,291 shares of common stock and (ii) 30,164 DSUs.

(8) As of January 31, 2025, Mr. Sayar held (i) 17,543 shares of common stock and (ii) 9,192 RSUs.

(9) As of January 31, 2025, Mr. Cahill held (i) 41,762 shares of common stock, (ii) 8,490 RSUs and (iii) 5,621 DSUs.

(10) As of January 31, 2025, Dr. Egbuonu-Davis held (i) 5,419 shares of common stock and (ii) 12,720 RSUs.

<div align='center'>30

PROPOSAL TWO:</div>

### RATIFICATION OF APPOINTMENT OF

### INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our audit committee has engaged KPMG LLP (“